Customized research for NAVB vs. AMGN!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for NAVB vs. AMGN.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Navidea Biopharmaceuticals, Inc vs. Amgen, Inc.

Industry Match! Industry of Both NAVB and AMGN:

Health Care/Life Sciences

NAVB
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 52.598M


P/E: N/A

P/S: 79.69

Q P/B: N/A

Y Rev: 657,826

Q Rev: 156,272

Beta: 1.14

NAVB Share Stats

Outstanding Shares

21.65M

Float Shares

14.26M

Percent of Float Short

3.73%

NAVB Insider Stats

Percent Outstanding Insider Ownership

98.79%

Percent Outstanding Institution Ownership

3.32%

NAVB Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

NAVB in Pulse Portal

Stream of Posts

NAVB Symbol Page

Share NAVB Insights

Express Sentiment

'Buy' or 'Sell' NAVB

NAVB Profile

CEO

Mr. Jed Andrew Latkin

Exchange

NYSE American

Employees

17.00

About

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is...

NAVB Financials

Annual Financials

Income Statement

Revenue

657,826

Net Income

(10.95M)

Cash Flow Statement

Change in Cash / Investments

(2.43M)

Balance Sheet

Cash / Investments

1.05M

Short Term Debt

556,508

Long Term Debt

None

Total Current Assets

2.92M

Total Current Liabilities

3.82M

Total Assets

4.15M

Total Liabilities

5.03M

Stockholder Equity

(1.61M)

Quarterly Financials

Income Statement

Q Revenue

156,272

Q Net Income

(2.67M)

Cash Flow Statement

Q Change in Cash / Investments

(445,804)

Balance Sheet

Q Cash / Investments

601,355

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

3.45M

Q Total Current Liabilities

4.35M

Q Total Assets

5.39M

Q Total Liabilities

5.57M

Q Stockholder Equity

(909,844)

NAVB Charts

10-Year Chart

NAVB 10-Year Chart

5-Year Chart

NAVB 5-Year Chart

1-Year Chart

NAVB 1-Year Chart

6-Month Chart

NAVB 6-Month Chart

3-Month Chart

NAVB 3-Month Chart

1-Month Chart

NAVB 1-Month Chart

1-Day Chart

NAVB 1-Day Chart

AMGN
Data Last Updated: 2 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 133.197B


P/E: 17.73

P/S: 5.73

Q P/B: 14.04

Y Rev: 23.26B

Q Rev: 6.11B

Beta: 0.98

AMGN Share Stats

Outstanding Shares

588.25M

Float Shares

586.97M

Percent of Float Short

1.34%

AMGN Insider Stats

Percent Outstanding Insider Ownership

0.51%

Percent Outstanding Institution Ownership

52.86%

AMGN Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

AMGN in Pulse Portal

Stream of Posts

AMGN Symbol Page

Share AMGN Insights

Express Sentiment

'Buy' or 'Sell' AMGN

AMGN Profile

CEO

Mr. Robert A. Bradway

Exchange

Nasdaq

Employees

23,400

About

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate,...

AMGN Financials

Annual Financials

Income Statement

Revenue

23.26B

Net Income

7.84B

Cash Flow Statement

Change in Cash / Investments

(908M)

Balance Sheet

Cash / Investments

8.91B

Short Term Debt

140M

Long Term Debt

26.95B

Total Current Assets

18.44B

Total Current Liabilities

12.84B

Total Assets

59.71B

Total Liabilities

50.03B

Stockholder Equity

9.67B

Quarterly Financials

Income Statement

Q Revenue

6.11B

Q Net Income

1.83B

Cash Flow Statement

Q Change in Cash / Investments

1.65B

Balance Sheet

Q Cash / Investments

8.01B

Q Short Term Debt

None

Q Long Term Debt

30.01B

Q Total Current Assets

18.81B

Q Total Current Liabilities

11.83B

Q Total Assets

61.67B

Q Total Liabilities

52.18B

Q Stockholder Equity

9.49B

AMGN Charts

10-Year Chart

AMGN 10-Year Chart

5-Year Chart

AMGN 5-Year Chart

1-Year Chart

AMGN 1-Year Chart

6-Month Chart

AMGN 6-Month Chart

3-Month Chart

AMGN 3-Month Chart

1-Month Chart

AMGN 1-Month Chart

1-Day Chart

AMGN 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon